Annual report pursuant to Section 13 and 15(d)

Shareholders??? Equity (Details Narrative)

v3.22.2
Shareholders’ Equity (Details Narrative)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 29, 2020
USD ($)
$ / shares
shares
Nov. 24, 2020
USD ($)
$ / shares
shares
May 10, 2020
USD ($)
May 01, 2020
shares
Nov. 08, 2017
USD ($)
Investors
$ / shares
shares
Jul. 25, 2017
USD ($)
May 10, 2017
USD ($)
Investors
shares
Mar. 31, 2021
USD ($)
shares
Sep. 30, 2020
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
shares
Mar. 15, 2021
USD ($)
Jan. 28, 2021
shares
Subsidiary, Sale of Stock [Line Items]                            
Stock issued during the period exercised                     756,540      
Gross proceeds from common stock | $                     $ 26,676,392 $ 11,339,375    
Gross proceeds from exercise of warrants | $                     2,261,337 5,182,403    
Gross proceeds from stock option exercised | $                     $ 363,139    
Preferred stock, shares authorized                     50,000,000 50,000,000    
Series A Convertible Preferred Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of preferred stock converted             2,583,000              
Number of shares issued upon conversion, convertible preferred stock             258,300              
Warrants description             The warrants have a term of seven years from the date of issuance are non-exercisable until 6 months after issuance, have an exercise price of $3.10 per share              
Series A Convertible Preferred Stock [Member] | First Closing [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrants to purchase             462,106              
Gross proceeds | $             $ 1,302,000              
Series A Convertible Preferred Stock [Member] | Second Closing [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrants to purchase             602,414              
Gross proceeds | $           $ 1,698,000                
Series A Preferred Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Preferred stock, shares authorized             12,000,000              
Series B Preferred Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Preferred stock, shares authorized         6,600,000                  
Series C Preferred Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Redemption of preferred shares                           26.697
Redemption of preferred stock | $                         $ 5,600,000  
Three Accredited Investors [Member] | Securities Purchase Agreement [Member] | Series A Convertible Preferred Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of accredited investors | Investors             3              
Proceeds from convertible preferred stock | $     $ 3,000,000       $ 3,000,000              
Description on preferred stock, conversion basis             The full $3,000,000 of Preferred Stock, and after giving effect to the reverse stock split and the previous conversion of 2,583,000 shares of Series A Preferred Stock into 258,300 shares of the Company’s common stock, is convertible into nine hundred, forty-one thousand, seven hundred and one shares of our common stock, based on a fixed conversion price of $2.50 per share on an as-converted basis              
Common Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares issued during the period               2,472,573   756,540        
Stock issued during the period exercised                     756,540 5,680,114    
Gross proceeds from exercise of warrants | $               $ 2,300,000            
Gross proceeds from stock option exercised | $                   $ 363,139        
Common Stock [Member] | ATM Program [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares issued during the period               21,398,765            
Gross proceeds from common stock | $               $ 27,800,000            
2018 Warrants [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares issued during the period                 5,642,114          
Warrants to purchase                 4,294,500          
Number of shares issued for warrants                 760,000          
Warrants exercise price per share | $ / shares                 $ 1.00          
2019 Warrants [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrants to purchase                 9,583,334          
Number of shares issued for warrants                 4,882,114          
Warrants exercise price per share | $ / shares                 $ 0.90          
2018 Warrants and 2019 Warrants [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Gross proceeds from exercise of warrants | $                 $ 5,153,902          
Warrant [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrants to purchase               2,472,573            
November 2020 Public Offering [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Proceeds from public offering | $   $ 6,000,000.0                        
November 2020 Public Offering [Member] | Dr. Frederick Telling [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrants to purchase   100,000                        
November 2020 Public Offering [Member] | Common Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares issued during the period   14,189,189                        
Share price per unit | $ / shares   $ 0.37                        
Stock issued during the period exercised   2,128,378                        
November 2020 Public Offering [Member] | Common Stock [Member] | Maximum [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares of stock available for purchase   2,128,378                        
December 2020 Registered Direct Offering [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Proceeds from public offering | $ $ 6,500,000                          
December 2020 Registered Direct Offering [Member] | Common Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares issued during the period 14,444,444                          
Share price per unit | $ / shares $ 0.45                          
Private Placement [Member] | Series B Convertible Preferred Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of accredited investors | Investors         4                  
Description on preferred stock, conversion basis         The full $3,300,000 of Series B Convertible Preferred Stock is convertible, after giving effect to the reverse stock split into one million three hundred and twenty thousand and two shares of our Common Stock, based on a conversion of one share of Series B Preferred Stock into two shares of Common Stock. The purchase price per share of the Series B Preferred Stock is represented by $2.50 per share of the Common Stock on an as converted basis                  
Proceeds from issuance of private placement | $         $ 3,300,000                  
Private Placement [Member] | Warrant [Member] | Series B Convertible Preferred Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrants to purchase         1,064,518                  
Warrants exercise price per share | $ / shares         $ 3.10                  
Term of warrants         7 years                  
Noachis Terra Inc. [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares issued during the period       9,200,000